Sincere Co., LTD. (7782) Stock Price

Market cap
¥3B
P/E ratio
11.7x
Sincere Corporation manufactures disposable contact lenses, provides medical clinic consulting services, and develops software systems for the reuse industry.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Sincere Corporation operates three business segments: contact lens business, consulting business, and systems business. Sincere manages these operations together with five consolidated subsidiaries.

In the contact lens business, Sincere manufactures and sells disposable clear contact lenses in daily wear, two-week replacement, and monthly replacement types. The "Sincere S Series" in particular has received high acclaim and serves as the company's flagship product.

In the consulting business, Sincere provides consulting services related to the operation of medical hair removal clinics. The company entered this field in November 2022 through business acquisition and offers web marketing and operational management support.

The systems business was launched through the subsidiary acquisition of Talos Systems Corporation. This segment designs, develops, sells, and maintains package systems for the reuse industry. The company aims to contribute to building an environmentally sustainable society.

Management Policy

Sincere Corporation aims to provide high-quality contact lenses at affordable prices to a diverse customer base. The company is improving its product development capabilities and expanding its business through web marketing, quality management, and enhanced sales capabilities. In particular, the company is focused on expanding its business scale through M&A.

Sincere targets increased sales of its "Sincere One Day S Series" through ophthalmology-affiliated retailers and contact lens mass-market retailers, while strengthening its management foundation and improving brand recognition. The company is also working to expand its drugstore channel presence and build trust with both business partners and end consumers. It is implementing measures to mitigate foreign exchange risks and promoting business diversification.

The company prioritizes revenue and operating profit, treating improvements in these metrics as key management objectives. While the contact lens market shows growth potential, intensifying competition has prompted Sincere to strengthen its sales and product capabilities. M&A acquisitions in the systems business have contributed to performance, resulting in increased revenue and operating profit.

Sincere faces challenges in strengthening product development capabilities, securing talent, and raising brand awareness. The company believes that product development and sales responsive to consumer needs are critical, and is pursuing flexible product development accordingly. It is also building an environment where diverse talent can thrive and strengthening its organizational structure to support sustainable growth.

Additionally, Sincere is reviewing its overseas business operations and pursuing enhanced profitability through efficient resource allocation. The company places emphasis on strengthening internal control systems and promoting compliance-based management to establish a foundation for sustainable growth. It is actively pursuing business expansion through M&A while seeking synergy effects.

AI Chat